Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 28, 2023 16:14 ET | Source: Recursion Pharmaceuticals

Recursion Publishes Second Annual Environmental, Social and Governance Report

Salt Lake City, March 28, 2023 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced...
March 01, 2023 08:00 ET | Source: Recursion Pharmaceuticals

Recursion to Participate in Upcoming Investor Conferences

SALT LAKE CITY, March 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced...
February 27, 2023 16:30 ET | Source: Recursion Pharmaceuticals

Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Initiated five clinical trials in 2022, including three Phase 2 programs, and provided guidance on the timing of clinical data readoutsDelivered against core elements of our Roche-Genentech...
February 21, 2023 11:00 ET | Source: Recursion Pharmaceuticals

Community Leaders Unite to Provide Support and Resources for Thousands of Utahns with Rare Diseases

Salt Lake City, Utah, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Rare Disease advocacy organizations and biotech and healthcare industry leaders will partner to accelerate the diagnosis and improve the care...